101 related articles for article (PubMed ID: 23528729)
21. Immunopeptidome mining reveals a novel ERS-induced target in T1D.
Wang L; Yang S; Zhu G; Li J; Meng G; Chen X; Zhang M; Wang S; Li X; Pan Y; Huang Y; Wang L; Wu Y
Cell Mol Immunol; 2024 Jun; 21(6):604-619. PubMed ID: 38689020
[TBL] [Abstract][Full Text] [Related]
22. T cell vaccination against autoimmune diabetes in nonobese diabetic mice.
Formby B; Shao T
Ann Clin Lab Sci; 1993; 23(2):137-47. PubMed ID: 8096128
[TBL] [Abstract][Full Text] [Related]
23. IDO-Expressing Fibroblasts Protect Islet Beta Cells From Immunological Attack and Reverse Hyperglycemia in Non-Obese Diabetic Mice.
Zhang Y; Jalili RB; Kilani RT; Elizei SS; Farrokhi A; Khosravi-Maharlooei M; Warnock GL; Ao Z; Marzban L; Ghahary A
J Cell Physiol; 2016 Sep; 231(9):1964-73. PubMed ID: 26743772
[TBL] [Abstract][Full Text] [Related]
24. Development of memory-like autoregulatory CD8+ T cells is CD4+ T cell dependent.
Shameli A; Clemente-Casares X; Wang J; Santamaria P
J Immunol; 2011 Sep; 187(6):2859-66. PubMed ID: 21824864
[TBL] [Abstract][Full Text] [Related]
25. CD8(+) T cells specific for beta cells encounter their cognate antigens in the islets of NOD mice.
Pang S; Zhang L; Wang H; Yi Z; Li L; Gao L; Zhao J; Tisch R; Katz JD; Wang B
Eur J Immunol; 2009 Oct; 39(10):2716-24. PubMed ID: 19658094
[TBL] [Abstract][Full Text] [Related]
26. A novel mimovirus encoding ChgA
Sun H; Han X; Yan X; Xu J; Huang Q; Meng F; Zhang H; Li S
Cell Immunol; 2017 Oct; 320():56-61. PubMed ID: 28916112
[TBL] [Abstract][Full Text] [Related]
27. Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library.
Wong FS; Karttunen J; Dumont C; Wen L; Visintin I; Pilip IM; Shastri N; Pamer EG; Janeway CA
Nat Med; 1999 Sep; 5(9):1026-31. PubMed ID: 10470079
[TBL] [Abstract][Full Text] [Related]
28. Apportioning Blame: Autoreactive CD4
Varela-Calvino R; Calviño-Sampedro C; Gómez-Touriño I; Cordero OJ
Arch Immunol Ther Exp (Warsz); 2017 Aug; 65(4):275-284. PubMed ID: 28083620
[TBL] [Abstract][Full Text] [Related]
29. Immunotherapy of type 1 diabetes.
Li L; Yi Z; Tisch R; Wang B
Arch Immunol Ther Exp (Warsz); 2008; 56(4):227-36. PubMed ID: 18726144
[TBL] [Abstract][Full Text] [Related]
30. Administration of a determinant of preproinsulin can induce regulatory T cells and suppress anti-islet autoimmunity in NOD mice.
Arai T; Moriyama H; Shimizu M; Sasaki H; Kishi M; Okumachi Y; Yasuda H; Hara K; Yokono K; Nagata M
Clin Immunol; 2010 Jul; 136(1):74-82. PubMed ID: 20359955
[TBL] [Abstract][Full Text] [Related]
31. Identification of autoreactive CD8+ T cell responses targeting chromogranin A in humanized NOD mice and type 1 diabetes patients.
Li Y; Zhou L; Li Y; Zhang J; Guo B; Meng G; Chen X; Zheng Q; Zhang L; Zhang M; Wang L
Clin Immunol; 2015 Jul; 159(1):63-71. PubMed ID: 25958206
[TBL] [Abstract][Full Text] [Related]
32. B lymphocytes are crucial antigen-presenting cells in the pathogenic autoimmune response to GAD65 antigen in nonobese diabetic mice.
Falcone M; Lee J; Patstone G; Yeung B; Sarvetnick N
J Immunol; 1998 Aug; 161(3):1163-8. PubMed ID: 9686575
[TBL] [Abstract][Full Text] [Related]
33. T cells in type 1 diabetes: Instructors, regulators and effectors: A comprehensive review.
Gomez-Tourino I; Arif S; Eichmann M; Peakman M
J Autoimmun; 2016 Jan; 66():7-16. PubMed ID: 26343335
[TBL] [Abstract][Full Text] [Related]
34. A CD8 DE loop peptide analog prevents graft-versus-host disease in a multiple minor histocompatibility antigen-mismatched bone marrow transplantation model.
Choksi S; Kim JC; Whitaker-Menezes D; Murphy GF; Friedman TM; Korngold R
Biol Blood Marrow Transplant; 2004 Oct; 10(10):669-80. PubMed ID: 15389433
[TBL] [Abstract][Full Text] [Related]
35. Beta-cell autoimmunity.
Fuchs YF; Adler K; Bonifacio E
Methods Mol Biol; 2012; 933():265-74. PubMed ID: 22893413
[TBL] [Abstract][Full Text] [Related]
36. The role of low avidity T cells in the protection against type 1 diabetes: a modeling investigation.
Khadra A; Santamaria P; Edelstein-Keshet L
J Theor Biol; 2009 Jan; 256(1):126-41. PubMed ID: 18950644
[TBL] [Abstract][Full Text] [Related]
37. Reversal of new-onset diabetes through modulating inflammation and stimulating beta-cell replication in nonobese diabetic mice by a dipeptidyl peptidase IV inhibitor.
Tian L; Gao J; Hao J; Zhang Y; Yi H; O'Brien TD; Sorenson R; Luo J; Guo Z
Endocrinology; 2010 Jul; 151(7):3049-60. PubMed ID: 20444936
[TBL] [Abstract][Full Text] [Related]
38. "Humanized" HLA transgenic NOD mice to identify pancreatic beta cell autoantigens of potential clinical relevance to type 1 diabetes.
Serreze DV; Marron MP; Dilorenzo TP
Ann N Y Acad Sci; 2007 Apr; 1103():103-11. PubMed ID: 17376821
[TBL] [Abstract][Full Text] [Related]
39. Developmental control of CD8 T cell-avidity maturation in autoimmune diabetes.
Han B; Serra P; Yamanouchi J; Amrani A; Elliott JF; Dickie P; Dilorenzo TP; Santamaria P
J Clin Invest; 2005 Jul; 115(7):1879-87. PubMed ID: 15937548
[TBL] [Abstract][Full Text] [Related]
40. Peptide-MHC-based nanomedicines for autoimmunity function as T-cell receptor microclustering devices.
Singha S; Shao K; Yang Y; Clemente-Casares X; Solé P; Clemente A; Blanco J; Dai Q; Song F; Liu SW; Yamanouchi J; Umeshappa CS; Nanjundappa RH; Detampel P; Amrein M; Fandos C; Tanguay R; Newbigging S; Serra P; Khadra A; Chan WCW; Santamaria P
Nat Nanotechnol; 2017 Jul; 12(7):701-710. PubMed ID: 28436959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
